Table 2 Overlap in patient comorbid conditions comprising CCI between coding algorithms
Comorbid Conditions, n (%) | 2013 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDCD (N = 328,740) | DOD (N = 804,707) | MDCD (N = 491,311) | DOD (N = 1,109,389) | |||||||||||||
Both | Neither | SNOMED CT only | Quan onlya | Both | Neither | SNOMED CT only | Quan onlya | Both | Neither | SNOMED CT Only | Quan Onlyb | Both | Neither | SNOMED CT Only | Quan onlyb | |
Myocardial infraction | 42,067 (12.8%) | 286,673 (87.2%) | 0 (0%) | 0 (0%) | 111,478 (13.9%) | 693,229 (86.1%) | 0 (0%) | 0 (0%) | 72,057 (14.7%) | 419,242 (85.3%) | 12 (0%) | 0 (0%) | 192,333 (17.3%) | 917,056 (82.7%) | 0 (0%) | 0 (0%) |
Congestive heart failure | 83,481 (25.4%) | 245,258 (74.6%) | 0 (0%) | 1 (0%) | 173,175 (21.5%) | 631,524 (78.5%) | 8 (0%) | 0 (0%) | 129,371 (26.3%) | 361,598 (73.6%) | 1 (0%) | 341 (0.1%) | 320,597 (28.9%) | 788,379 (71.1%) | 3 (0%) | 410 (0%) |
Peripheral vascular disease | 73,381 (22.3%) | 255,110 (77.6%) | 249 (0.1%) | 0 (0%) | 212,337 (26.4%) | 591,873 (73.6%) | 497 (0.1%) | 0 (0%) | 121,219 (24.7%) | 368,043 (74.9%) | 2,049 (0.4%) | 0 (0%) | 378,005 (34.1%) | 726,278 (65.5%) | 5,106 (0.5%) | 0 (0%) |
Cerebrovascular disease | 83,030 (25.3%) | 245,699 (74.7%) | 11 (0%) | 0 (0%) | 227,045 (28.2%) | 577,652 (71.8%) | 10 (0%) | 0 (0%) | 121,824 (24.8%) | 369,394 (75.2%) | 93 (0%) | 0 (0%) | 351,659 (31.7%) | 757,659 (68.3%) | 71 (0%) | 0 (0%) |
Dementia | 26,351 (8%) | 292,719 (89%) | 9,670 (2.9%) | 0 (0%) | 46,465 (5.8%) | 739,610 (91.9%) | 18,632 (2.3%) | 0 (0%) | 47,300 (9.6%) | 441,999 (90%) | 2,012 (0.4%) | 0 (0%) | 125,035 (11.3%) | 981,431 (88.5%) | 2,923 (0.3%) | 0 (0%) |
Chronic pulmonary disease | 167,148 (50.8%) | 161,374 (49.1%) | 201 (0.1%) | 17 (0%) | 328,056 (40.8%) | 476,046 (59.2%) | 532 (0.1%) | 73 (0%) | 261,150 (53.2%) | 230,061 (46.8%) | 89 (0%) | 11 (0%) | 491,359 (44.3%) | 617,787 (55.7%) | 177 (0%) | 66 (0%) |
Rheumatic disease | 21,326 (6.5%) | 306,076 (92.1%) | 1,338 (1.5%) | 0 (0%) | 59,090 (7.3%) | 740,327 (90.2%) | 5,285 (2.4%) | 5 (0%) | 32,366 (6.6%) | 454,299 (91.7%) | 4,646 (1.7%) | 0 (0%) | 92,570 (8.3%) | 1,001,694 (89.3%) | 15,122 (2.4%) | 3 (0%) |
Peptic ulcer disease | 21,419 (6.5%) | 307,321 (93.5%) | 0 (0%) | 0 (0%) | 45,029 (5.6%) | 759,678 (94.4%) | 0 (0%) | 0 (0%) | 33,855 (6.9%) | 457,456 (93.1%) | 0 (0%) | 0 (0%) | 70,761 (6.4%) | 1,038,628 (93.6%) | 0 (0%) | 0 (0%) |
Mild liver disease | 48,863 (14.9%) | 279,058 (84.9%) | 819 (0.2%) | 0 (0%) | 115,402 (14.3%) | 688,390 (85.5%) | 915 (0.1%) | 0 (0%) | 100,175 (20.4%) | 388,077 (79%) | 3,059 (0.6%) | 0 (0%) | 193,778 (17.5%) | 910,855 (82.1%) | 4,756 (0.4%) | 0 (0%) |
Diabetes without chronic complications | 12,3547 (37.6%) | 205,188 (62.4%) | 5 (0%) | 0 (0%) | 268,552 (33.4%) | 536,128 (66.6%) | 27 (0%) | 0 (0%) | 178,907 (36.4%) | 310,600 (63.2%) | 1,800 (0.4%) | 4 (0%) | 436,702 (39.4%) | 668,234 (60.2%) | 4,395 (0.4%) | 58 (0%) |
Diabetes with chronic complications | 54,233 (16.5%) | 262,103 (79.7%) | 12,404 (3.8%) | 0 (0%) | 117,527 (14.6%) | 668,089 (83%) | 19,091 (2.4%) | 0 (0%) | 111,701 (22.7%) | 367,442 (74.8%) | 12,168 (2.5%) | 0 (0%) | 267,237 (24.1%) | 816,215 (73.6%) | 25,937 (2.3%) | 0 (0%) |
Hemiplegia or paraplegia | 23,420 (7.1%) | 304,992 (92.8%) | 328 (0.1%) | 0 (0%) | 30,170 (3.7%) | 773,905 (96.2%) | 632 (0.1%) | 0 (0%) | 40,428 (8.2%) | 449,533 (91.5%) | 1,350 (0.3%) | 0 (0%) | 58,900 (5.3%) | 1,048,834 (94.5%) | 1,655 (0.1%) | 0 (0%) |
Renal disease | 65,131 (19.8%) | 259,399 (78.9%) | 4,210 (1.3%) | 0 (0%) | 161,663 (20.1%) | 634,201 (78.8%) | 8,843 (1.1%) | 0 (0%) | 102,761 (20.9%) | 384,814 (78.3%) | 3,736 (0.8%) | 0 (0%) | 325,401 (29.3%) | 779,363 (70.3%) | 4,625 (0.4%) | 0 (0%) |
Malignancy, except skin neoplasms | 38,912 (11.8%) | 288,626 (87.8%) | 1,202 (0.4%) | 0 (0%) | 158,319 (19.7%) | 643,288 (79.9%) | 3,100 (0.4%) | 0 (0%) | 58,426 (11.9%) | 430,812 (87.7%) | 2,073 (0.4%) | 0 (0%) | 241,187 (21.7%) | 861,474 (77.7%) | 6,728 (0.6%) | 0 (0%) |
Moderate or severe liver disease | 7,262 (2.2%) | 321,478 (97.8%) | 0 (0%) | 0 (0%) | 10,881 (1.4%) | 793,820 (98.6%) | 6 (0%) | 0 (0%) | 13,194 (2.7%) | 475,937 (96.9%) | 2,180 (0.4%) | 0 (0%) | 19,882 (1.8%) | 1,085,157 (97.8%) | 4,350 (0.4%) | 0 (0%) |
Metastatic solid tumor | 12,248 (3.7%) | 316,279 (96.2%) | 213 (0.1%) | 0 (0%) | 42,151 (5.2%) | 761,866 (94.7%) | 690 (0.1%) | 0 (0%) | 18,820 (3.8%) | 471,549 (96%) | 942 (0.2%) | 0 (0%) | 64,521 (5.8%) | 1,042,617 (94%) | 2,251 (0.2%) | 0 (0%) |
AIDS/HIV | 5,437 (1.7%) | 323,303 (98.3%) | 0 (0%) | 0 (0%) | 3,124 (0.4%) | 801,583 (99.6%) | 0 (0%) | 0 (0%) | 7,471 (1.5%) | 483,840 (98.5%) | 0 (0%) | 0 (0%) | 4,850 (0.4%) | 1,104,539 (99.6%) | 0 (0%) | 0 (0%) |